New FDA Guidance for Cancer Clinical Trial Eligibility Criteria

New FDA guidances provide recommendations regarding eligibility criteria for clinical trials of drugs or biological products regulated by CDER and CBER for the treatment of cancer.

They include the following:

Follow this blog